Please ensure Javascript is enabled for purposes of website accessibility

Which Company Is Best at Mobile Health?

By Rex Moore and Max Macaluso - Feb 6, 2014 at 6:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sanofi and Johnson & Johnson are among the early leaders in the exciting intersection of technology and wireless, mobile health.

As the health-care industry evolves, success for many companies may depend on their ability to embrace wireless solutions and mobile health technologies. Which companies are already headed in that direction?

According to Robert McCray of the Wireless-Life Sciences Alliance, both Sanofi (SNY -1.27%) and Johnson & Johnson (JNJ -0.53%) seem to understand this space extremely well.

A full transcript follows the video.

Max Macaluso: Is there one company in your mind that's embracing new technology and wireless health, in a way that some of the others aren't?

Robert McCray: The biggest company is one of the early ones to adopt this notion and figure it out -- because it's a figuring-it-out process -- is Sanofi (SNY -1.27%), the Paris-based company. They have an entire unit that is focused on digital and connected health, and they're working hard to figure out how to build platforms that work in traditional health care and drive more compliance, and even look for digital therapeutics that are competitor to, but better than, traditional therapeutics. They're certainly one that comes to mind.

Johnson & Johnson (JNJ -0.53%), as I mentioned, is working in this space to try to figure it out. All of the companies that have come to us are trying to figure it out. They're at different levels, and how well they are doing is dictated by their different circumstances. 

Max Macaluso, Ph.D., has no position in any stocks mentioned. Rex Moore owns shares of Johnson & Johnson. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$170.20 (-0.53%) $0.91
Sanofi Stock Quote
Sanofi
SNY
$49.08 (-1.27%) $0.63

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.